 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Current Price	$3.06
Prev Close	$2.89
Open	$2.87
Dividend Yield	0.00%
50-Day Moving Average	$3.05
Beta	0.93
Avg. Volume	12,471.45
PE Ratio	-0.48

52-Week High	$24.00
52-Week Low	$2.60
Market Capitalization	$6.19M
EPS	-$6.38
Price to Book	0.71
Revenue Per Employee	$22,243.67
Enterprise Value/EBITDA	0.04

OGEN Oragenics Inc

About

Feed

Fundamentals

News